Shariah compliance overview
Not HalalImmix Biopharma, Inc. (IMMX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Immix Biopharma, Inc.
Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases.
Immix Biopharma, Inc. (IMMX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 60.97%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Immix Biopharma, Inc. (IMMX). Current Akinda screening label: Not Halal.
